157 related articles for article (PubMed ID: 12831337)
1. The imidazoquinolines and their place in the therapy of cutaneous disease.
Smith KJ; Hamza S; Skelton H
Expert Opin Pharmacother; 2003 Jul; 4(7):1105-19. PubMed ID: 12831337
[TBL] [Abstract][Full Text] [Related]
2. Imiquimod.
Garland SM
Curr Opin Infect Dis; 2003 Apr; 16(2):85-9. PubMed ID: 12734440
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod; an international update on therapeutic uses in dermatology.
Tyring S; Conant M; Marini M; Van Der Meijden W; Washenik K
Int J Dermatol; 2002 Nov; 41(11):810-6. PubMed ID: 12453012
[TBL] [Abstract][Full Text] [Related]
4. Beyond a decade of 5% imiquimod topical therapy.
A Gaspari A; Tyring SK; Rosen T
J Drugs Dermatol; 2009 May; 8(5):467-74. PubMed ID: 19537370
[TBL] [Abstract][Full Text] [Related]
5. Imiquimod: a cytokine inducer.
Dahl MV
J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S205-8. PubMed ID: 12271278
[No Abstract] [Full Text] [Related]
6. Using imiquimod for genital warts in female patients.
Cox JT; Petry KU; Rylander E; Roy M
J Womens Health (Larchmt); 2004 Apr; 13(3):265-71. PubMed ID: 15130255
[TBL] [Abstract][Full Text] [Related]
7. Topical immunomodulators for the treatment of external genital warts, cutaneous warts and molluscum contagiosum.
Hengge UR; Cusini M
Br J Dermatol; 2003 Nov; 149 Suppl 66():15-9. PubMed ID: 14616340
[TBL] [Abstract][Full Text] [Related]
8. [New perspective in immunotherapy: local imiquimod treatment].
Kemény L; Nagy N
Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
[TBL] [Abstract][Full Text] [Related]
9. Imiquimod.
Skinner RB
Dermatol Clin; 2003 Apr; 21(2):291-300. PubMed ID: 12757252
[TBL] [Abstract][Full Text] [Related]
10. Imiquimod: mode of action and therapeutic potential.
Chosidow O; Dummer R
Acta Derm Venereol Suppl (Stockh); 2003 Sep; (214):8-11. PubMed ID: 14606276
[No Abstract] [Full Text] [Related]
11. Topical imidazoquinoline therapy of cutaneous squamous cell carcinoma polarizes lymphoid and monocyte/macrophage populations to a Th1 and M1 cytokine pattern.
Smith KJ; Hamza S; Skelton H
Clin Exp Dermatol; 2004 Sep; 29(5):505-12. PubMed ID: 15347337
[TBL] [Abstract][Full Text] [Related]
12. Topical imiquimod: a review of its use in genital warts.
Perry CM; Lamb HM
Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
[TBL] [Abstract][Full Text] [Related]
13. Imiquimod 5 percent cream and the treatment of cutaneous malignancy.
Navi D; Huntley A
Dermatol Online J; 2004 Jul; 10(1):4. PubMed ID: 15347486
[TBL] [Abstract][Full Text] [Related]
14. [Topical imiquimod cream in the treatment of external anogenital warts: personal experience].
Senatori R; Dionisi B; Lippa P; Inghirami P
Minerva Ginecol; 2003 Dec; 55(6):541-6. PubMed ID: 14676745
[TBL] [Abstract][Full Text] [Related]
15. Imiqimod in clinical practice.
Trofatter KF
Eur J Dermatol; 1998; 8(7 Suppl):17-9; discussion 20-2. PubMed ID: 10387959
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 7 agonists and skin.
Novak N; Yu CF; Bieber T; Allam JP
Drug News Perspect; 2008 Apr; 21(3):158-65. PubMed ID: 18560614
[TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of imiquimod indirect antiviral activity].
Hober D; Ajram L; Chehadeh W; Lazrek M; Goffard A; Dewilde A; Wattré P
Ann Biol Clin (Paris); 2005; 63(2):155-63. PubMed ID: 15771973
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of imiquimod for the therapy of external genital and anal warts in comparison with destructive therapies.
Schöfer H
Br J Dermatol; 2007 Dec; 157 Suppl 2():52-5. PubMed ID: 18067633
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic approaches to genital warts.
Beutner KR; Ferenczy A
Am J Med; 1997 May; 102(5A):28-37. PubMed ID: 9217660
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder.
Smith EB; Schwartz M; Kawamoto H; You X; Hwang D; Liu H; Scherr DS
J Urol; 2007 Jun; 177(6):2347-51. PubMed ID: 17509356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]